Recall Register

Food, drugs, devices › Luminex Corporation

Device recall: Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (

FDA enforcement event 81890 · Class III · initiated 26 Dec 2018 · status Terminated · terminated 4 Aug 2020

DeviceVoluntary: Firm initiated1 product recordAustin, TX

FDA enforcement event 81890 is a device recall by Luminex Corporation of Austin, TX, initiated 26 Dec 2018 and classified Class III, with 1 product record.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 4% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 4 Aug 2020. Initiation: voluntary: firm initiated. Luminex Corporation has 24 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Luminex Corporation, Austin, TX.

Reason for recall

"On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label."

Distribution

"Worldwide Distribution: US (nationwide) and countries of: Austria, and Italy."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0822-2019Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic…1132 carriersClass IIITerminated20 Feb 2019

Context

4%of 2018 device events are Class III1,074 events that year
1product record in this eventfirm median: 1
24events on this register for the firm

Other enforcement events for Luminex Corporation

InitiatedProduct (first record)TypeClassRecords
16 Apr 2025VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGDeviceClass II1
20 Jun 2024Verigene Gram Positive Blood Culture (BC-GP) Nucleic Acid TestDeviceClass II1
7 Nov 2023Luminex VERIGENE BC-GP Utility Tray (5-Pack Carrier), Gram-Positive Blood Culture Nucleic Acid Test, REF 20-011-018, a cDeviceClass II1
5 Jun 2023Verigene Enteric Pathogens Nucleic Acid Test (EP), REF 30-002-023DeviceClass II2
14 Sep 2022ARIES SARS-CoV-2 Assay, REF: 50-10047DeviceClass II1
14 Jul 2022ARIES SARS-CoV-2 AssayDeviceClass II1
17 Jun 2022Verigene CDF Nucleic Acid Test, Part No. 30-002-22DeviceClass II2
5 Apr 2022Verigene Processor SP, Models 10-0000-07/10-0000-07R a component of the Verigene systemDeviceClass II1
15 Feb 2022VERIGENE Nucleic Acid Test Kit-BC-GN Extraction Tray - 9.73 mL, REF 20-009-021DeviceClass II1
17 Nov 2021ARIES HSV 1&2 Assay, Catalog/REF# 50-10017DeviceClass II1

All 24 events for Luminex Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution: US (nationwide) and countries of: Austria, and Italy."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 Aug 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.